Literature DB >> 10701800

Interstitial cystitis and the potential role of gabapentin.

H C Hansen1.   

Abstract

Gabapentin, an antiepileptic agent, is a safe and versatile medication also used in the adjunctive treatment of painful disorders. These include neuropathic pain, such as postherpetic neuralgia, diabetic neuropathy, and the pain of reflex sympathetic dystrophy. Interstitial cystitis, a painful disease entity, shares many common features of these chronic pain states, and the use of gabapentin can assist in pain control. Gabapentin, as an adjunctive agent, may reduce use of cotherapeutics such as narcotics. Two patients with interstitial cystitis improved functional capacity within their activities of daily living and received adequate pain control with the addition of gabapentin to their medication regimen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10701800

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

1.  The role of pregabalin in relieving ureteral stent-related symptoms: a randomized controlled clinical trial.

Authors:  Maged Ragab; Mohamed G Soliman; Ahmed Tawfik; Ali Abdel Raheem; Hassan El-Tatawy; Mohamed Abo Farha; Michael Magdy; Osama Elashry
Journal:  Int Urol Nephrol       Date:  2017-03-04       Impact factor: 2.370

2.  A case of perineal pain related to interstitial cystitis which was supposed to be relieved with gabapentin.

Authors:  Junji Takatani; Naozumi Takeshima; Kentaro Okuda; Hiroshi Miyakawa; Takayuki Noguchi
Journal:  J Anesth       Date:  2009-08-14       Impact factor: 2.078

3.  CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Ashley Cox; Nicole Golda; Genevieve Nadeau; J Curtis Nickel; Lesley Carr; Jacques Corcos; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

4.  Role of inflammation in bladder function and interstitial cystitis.

Authors:  Sonal Grover; Abhishek Srivastava; Richard Lee; Ashutosh K Tewari; Alexis E Te
Journal:  Ther Adv Urol       Date:  2011-02

5.  Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain.

Authors:  Nasim Zabihi; Arthur Mourtzinos; Mary Grey Maher; Shlomo Raz; Larissa V Rodríguez
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-10-10

6.  Blocking α2δ-1 Subunit Reduces Bladder Hypersensitivity and Inflammation in a Cystitis Mouse Model by Decreasing NF-kB Pathway Activation.

Authors:  Ludivine Boudieu; Sarah Mountadem; Amandine Lashermes; Mathieu Meleine; Lauriane Ulmann; François Rassendren; Youssef Aissouni; Benoit Sion; Frédéric Antonio Carvalho; Denis Ardid
Journal:  Front Pharmacol       Date:  2019-02-26       Impact factor: 5.810

Review 7.  Early identification of interstitial cystitis may avoid unnecessary hysterectomy.

Authors:  Maurice K Chung; Barry Jarnagin
Journal:  JSLS       Date:  2009 Jul-Sep       Impact factor: 2.172

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.